Abiopharma

🔍 Fischer David B (Director)

Company: Ingredion Inc (INGR)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 380 shares of Common Stock at $111.92 per share (Direct)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 19,510.24 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter.
• F2: Includes restricted stock units ("RSUs") acquired through deemed dividend reinvestment. RSUs acquired through deemed dividend reinvestment vest on the dates when the RSUs with respect to which they are deemed dividends vest.